Condition: Pneumothorax · Biopsy, Needle · Risk Factors · Sponsor: Insel Gruppe AG, University Hospital Bern
The purpose of this randomized controlled study is to evaluate the extent to which injection of a small amount of fluid in the pleural cavity at the biopsy site may reduce the risk of pneumothoraces, in addition to patient positioning to allow biopsy in gravity-dependent areas of the lung.
This description comes directly from the study's public registry record.
Michael Brönnimann, MD · +41316326510 · michael.broennimann@insel.ch
Johannes Heverhagen, Prof · +41316322648 · johannes.heverhagen@insel.ch
Always discuss trial participation with your own doctor first.
| Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 10 | Bern, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06340178